Mahamaya Lifesciences IPO Date, Review, Price, Allotment Details
The Mahamaya Lifesciences IPO will open for subscription on November 11, 2025, and close on November 13, 2025. It is a Book Built Issue, through which the company aims to raise approximately ₹70.44 crores. The issue comprises a fresh issue of ₹64.28 crores and an offer for sale of up to 5,40,800 equity shares with a face value of ₹10 each.
The IPO price band is fixed at ₹108 to ₹114 per share, with a retail investor quota of 35%, QIB quota of 50%, and HNI quota of 15%. The IPO allotment is expected to be finalized on November 14, 2025, and the listing is likely to take place on the BSE on November 18, 2025.
In terms of financial performance, Mahamaya Lifesciences Limited reported a revenue of ₹267.17 crores in 2025, up from ₹162.83 crores in 2024. The company’s profit also rose to ₹12.94 crores in 2025 compared to ₹5.22 crores in 2024. Based on its strong financial growth, the IPO appears to be a good option for long-term investors.
Mahamaya Lifesciences IPO Details
IPO Open Date November 11, 2025 IPO Close Date November 13, 2025 Face Value ₹10 Per Equity Share IPO Price Band ₹108 to ₹114 Per Share Issue Size Approx ₹70.44 Crores Fresh Issue Approx ₹64.28 Crores Offer for Sale: Approx 5,40,000 Equity Shares Issue Type Book Built Issue IPO Listing BSE SME DRHP Draft Prospectus 
RHP Draft Prospectus
Mahamaya Lifesciences IPO Market Lot
The minimum market lot for the Mahamaya Lifesciences IPO is 2,400 shares, requiring a minimum application amount of ₹2,73,600.
Application Lot Size Shares Amount Retail Minimum 2 2,400 ₹2,73,600 Retail Maximum 2 2,400 ₹2,73,600 S-HNI Minimum 3 3,600 ₹4,10,400 S-HNI Maximum 7 8,400 ₹9,57,600 B-HNI Minimum 8 9,600 ₹10,94,400
IPO Reservation
Investor Category Share Offered -% Shares Anchor Investor – Shares -% QIB (Ex. Anchor) 29,28,000 47.39% NII Shares Offered 8,82,000 14.27% Retail Shares Offered 20,59,200 33.33%
Mahamaya Lifesciences IPO Anchor Investors
| Bid Date | November 10, 2025 |
| Shares Offered | 17,52,000 |
| Anchor Portion Size (In Cr.) | 19.97 |
| Anchor lock-in period end date for 50% shares (30 Days) | December 14, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | February 12, 2026 |
Mahamaya Lifesciences IPO Dates
The Mahamaya Lifesciences IPO will open on November 11, 2025, and close on November 13, 2025. The IPO allotment is expected to be finalized on November 14, 2025, with the listing date scheduled for November 18, 2025.
IPO Open Date: November 11, 2025 IPO Close Date: November 13, 2025 Basis of Allotment: November 14, 2025 Refunds: November 17, 2025 Credit to Demat Account: November 17, 2025 IPO Listing Date: November 18, 2025 IPO Bidding Cut-off Time: November 13, 2025 – 5 PM
Promoters and Holding Pattern
The promoters of Mahamaya Lifesciences Limited are Mr. Krishnamurthy Ganesan, Mr. Prashant Krishnamurthy, and Mrs. Lalitha Krishnamurthy.
Particular Shares % Share Promoter Holding Pre Issue 1,77,66,200 77.27% Promoter Holding Post Issue 2,34,05,000 56.35%
Objects of the Issue & Utilisation of Proceeds
Purpose Crores Purchase of equipment for the existing formulation plant. ₹3.75 Funding capital expenditure towards setting up a new technical manufacturing plant. ₹29.42 Construction of Warehouse Building and Purchase of Machinery. ₹2.53 Funding the working capital requirement of the company. ₹18.00 General corporate purposes. ₹-
About Mahamaya Lifesciences IPO
Mahamaya Lifesciences Limited, established in 2002, is a leading company engaged in the manufacturing of pesticide formulations and the supply of bulk formulations. In collaboration with the Central Insecticides Board and Registration Committee (CIBRC), the company began its operations by importing and registering key pesticide molecules that were not previously produced in India. Following successful registrations, it started marketing these molecules as technical products to both Indian agrochemical companies and multinational corporations (MNCs).
Over the years, Mahamaya Lifesciences has achieved significant growth, marked by the establishment of its state-of-the-art manufacturing facility at Dahej, Gujarat, in December 2021. The company’s products have a strong presence across multiple Indian states, including Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana, while also expanding its export network to countries such as Turkey, Egypt, and the UAE.
Mahamaya Lifesciences IPO Company Financial Report
Amount in Crores (₹)
Period Ended Revenue Expense PAT Assets 2022 ₹90.16 ₹86.43 ₹2.72 ₹55.71 2023 ₹137.40 ₹132.30 ₹3.75 ₹77.88 2024 ₹162.83 ₹155.71 ₹5.22 ₹112.07 2025 ₹267.17 ₹249.81 ₹12.94 ₹188.35 June 2025 ₹84.04 ₹78.35 ₹4.10 ₹218.87
Mahamaya Lifesciences IPO Valuation – FY2025
Check Mahamaya Lifesciences IPO valuation details like Earnings Per Share (EPS), Price/Earnings (P/E) Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI Values ROE: 34.94% ROCE: 23.15% EBITDA Margin: 9.22% PAT Margin: 4.84% Debt to equity ratio: 1.08 Earning Per Share (EPS): ₹7.60 (Basic) Price/Earning (P/E) Ratio: N/A Return on Net Worth (RoNW): 26.19% Net Asset Value (NAV): ₹27.82
Peer Group Comparison
Company EPS PE Ratio RoNW % NAV Income Nova Agritech Limited 3.05 16.93 12.47% 23.76 296.60 Cr. Bhagiradha Chemicals & Industries Limited 1.14 247.63 2.03% 52.61 449.75 Cr.
IPO Lead Managers aka Merchant Bankers
- Oneview Corporate Advisors Pvt. Ltd.
Company Address
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: mahamaya.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/